COMPASS Pathways Plc American Depository Shares (CMPS) vs Kardigan (KARD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
COMPASS Pathways Plc American Depository Shares is the larger company by market cap ($1.14 billion vs $1.08 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CMPS | KARD |
|---|---|---|
| Share price | $8.05 | $11.54 |
| Market cap | $1.14B | $1.08B |
| 1-day change | -6.94% | -7.83% |
| YTD return | +16.67% | — |
| 1-year return | +55.71% | — |
| 5-year return | -75.42% | — |
| EPS (TTM) | $-2.34 | $-6.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-287.86M | — |
| 52-week high | $15.87 | $27.00 |
| 52-week low | $4.88 | $11.49 |
| Distance from 52-week high | -49.28% | -57.26% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +189.57% | +255.29% |
| Average volume | 3.09M | 625.83K |
| Shares outstanding | 141.71M | 93.60M |
| Employees | 156 | 241 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About COMPASS Pathways Plc American Depository Shares
CMPS stock →COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa.
Health Care · Biotechnology: Pharmaceutical Preparations · 156 employees
About Kardigan
KARD stock →Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 241 employees
CMPS vs KARD FAQ
Which is bigger, COMPASS Pathways Plc American Depository Shares or Kardigan?
COMPASS Pathways Plc American Depository Shares (CMPS) is larger, with a market capitalization of $1.14B compared with $1.08B for Kardigan (KARD).
Are COMPASS Pathways Plc American Depository Shares and Kardigan in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.